by Joel Rothman | Nov 16, 2009 | NutriSupLaw
Two days of hearings before the FDA about search-based advertising for drugs produced one possible solution: fixed warnings for products. Google has proposed that its AdWords could include a hyper-linked line that warns consumers about the potential dangers of a drug....
by Joel Rothman | Nov 13, 2009 | NutriSupLaw
Ever since receiving FDA notices about their advertising generated from Google and similar searches, drugmakers have toned down their language and sought clarity on what is allowed. The discussion has ramifications for makers of nutritional supplements, because they...
by Joel Rothman | Sep 18, 2009 | NutriSupLaw
In the trade, it is called public service journalism, but this may qualify more as a disservice. In the Sept. 21 issue with Tim Tebow on the cover (again?), ESPN Magazine devotes two well-illustrated and detailed pages on performance-enhancing drugs. This is a must...
by Joel Rothman | Sep 9, 2009 | NutriSupLaw
We are not sure of the reason, but it seems that every three months or so, a national media outlet weighs in on an old story: tainted nutritional supplements. To be sure, the story will not go away in the sports world. Athletes who test positive for steroids often say...
by Joel Rothman | Aug 10, 2009 | NutriSupLaw
Notice anything different? You should. To celebrate the start of our fifth year, we gave the blog a makeover. Or as they say on the Web, a redesign. We think the new look does a better job of displaying blog entries and organizing our growing lists of resources, links...
